These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1240 related articles for article (PubMed ID: 22677369)

  • 1. A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy.
    Pasquier D; Cavillon F; Lacornerie T; Touzeau C; Tresch E; Lartigau E
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):549-54. PubMed ID: 22677369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer.
    Davidson MT; Blake SJ; Batchelar DL; Cheung P; Mah K
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1550-8. PubMed ID: 21543164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
    Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
    Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
    Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
    Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric analysis of three-dimensional conformal radiotherapy, intensity-modulated radiotherapy-step and shoot, helical tomotherapy, and volumetric modulated arc therapy in prostate cancer radiotherapy.
    Gozal F; Gondhowiardjo SA; Kodrat H; Wibowo WE
    J Cancer Res Ther; 2021; 17(4):893-900. PubMed ID: 34528538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
    Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative planning study of step-and-shoot IMRT versus helical tomotherapy for whole-pelvis irradiation in cervical cancer.
    Chitapanarux I; Tharavichitkul E; Nobnop W; Wanwilairat S; Vongtama R; Traisathit P
    J Radiat Res; 2015 May; 56(3):539-45. PubMed ID: 25720771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role and strategy of IMRT in radiotherapy of pelvic tumors: Dose escalation and critical organ sparing in prostate cancer.
    Liu YM; Shiau CY; Lee ML; Huang PI; Hsieh CM; Chen PH; Lin YH; Wang LW; Yen SH
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1113-23. PubMed ID: 17197126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes.
    Yoo S; Wu QJ; Lee WR; Yin FF
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):935-42. PubMed ID: 20044214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-pelvic volumetric-modulated arc therapy for high-risk prostate cancer: treatment planning and acute toxicity.
    Ishii K; Ogino R; Hosokawa Y; Fujioka C; Okada W; Nakahara R; Kawamorita R; Tada T; Hayashi Y; Nakajima T
    J Radiat Res; 2015 Jan; 56(1):141-50. PubMed ID: 25304328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
    Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT.
    Kuang Y; Wu L; Hirata E; Miyazaki K; Sato M; Kwee SA
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1017-25. PubMed ID: 25832692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric comparison between helical tomotherapy and volumetric modulated arc-therapy for non-anaplastic thyroid cancer treatment.
    Khalifa J; Vieillevigne L; Boyrie S; Ouali M; Filleron T; Rives M; Laprie A
    Radiat Oncol; 2014 Nov; 9():247. PubMed ID: 25424320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study.
    Ost P; Speleers B; De Meerleer G; De Neve W; Fonteyne V; Villeirs G; De Gersem W
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):920-6. PubMed ID: 20675077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and dosimetric advantages between VMAT, IMRT, and helical tomotherapy in prostate cancer.
    Tsai CL; Wu JK; Chao HL; Tsai YC; Cheng JC
    Med Dosim; 2011; 36(3):264-71. PubMed ID: 20634054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VMAT partial arc technique decreases dose to organs at risk in whole pelvic radiotherapy for prostate cancer when compared to full arc VMAT and IMRT.
    Bartlett GK; Njeh CF; Huang KC; DesRosiers C; Guo G
    Med Dosim; 2023 Spring; 48(1):8-15. PubMed ID: 36319515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the "Hostile Pelvis" for Intensity Modulated Radiation Therapy: The Impact of Anatomic Variations in Pelvic Dimensions on Dose Delivered to Target Volumes and Organs at Risk in Patients With High-Risk Prostate Cancer Treated With Whole Pelvic Radiation Therapy.
    Yirmibeşoğlu Erkal E; Karabey S; Karabey A; Hayran M; Erkal HŞ
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):894-903. PubMed ID: 26104941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric study of volumetric modulated arc therapy fields for total marrow irradiation.
    Han C; Schultheisss TE; Wong JY
    Radiother Oncol; 2012 Feb; 102(2):315-20. PubMed ID: 21724284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy.
    Kannarunimit D; Descovich M; Garcia A; Chen J; Weinberg V; Mcguinness C; Pinnaduwage D; Murnane J; Gottschalk AR; Yom SS
    Technol Cancer Res Treat; 2015 Feb; 14(1):49-60. PubMed ID: 24325136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.